Selective serotonin reuptake inhibitors were less cost effective than initial treatment with tricyclic antidepressants
Matthew H. Hotopf
Abstract
Open-access reader
Matthew H. Hotopf
Abstract
Open-access reader
Selective serotonin reuptake inhibitors were less cost effective than initial treatment with tricyclic antidepressants Canadian Coordinating Office for Health Technology Assessment. Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part II. The cost-effectiveness of SSRIs in treatment of depression. Ottawa: Canadian
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Selective serotonin reuptake inhibitors were less cost effective than initial treatment with tricyclic antidepressants Canadian Coordinating Office for Health Technology Assessment. Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part II. The cost-effectiveness of SSRIs in treatment of depression. Ottawa: Canadian
Key concepts: Tricyclic, Serotonin Uptake Inhibitors, Reuptake inhibitor, Serotonin, Medicine, Tricyclic antidepressant, Pharmacology, Antidepressant